Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years
International Journal of Radiation Oncology*Biology*PhysicsPublished 1 September 2000
Mitchell S. Anscher, Robert Clough, Richard K. Dodge
Citations175
SJR quartileQ1
SJR score2.06
SNIP1.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Pvic RT may achieve sustained remission of prostate cancer for about half of patients with a rising PSA after radical prostatectomy, at least in the intermediate term, and 3DRT may offer improved disease-free survival over non-3D approaches.
Abstract
Pelvic RT may achieve sustained remission of prostate cancer for about half of patients with a rising PSA after RP, at least in the intermediate term. Doses > 65 Gy are recommended. 3DRT may offer improved disease-free survival over non-3D approaches, however, this issue requires further study.
Keywords
MedicinePhysics and Astronomy
Springer series in statisticsNonparametric Estimation from Incomplete Observations
45,533 Citations1992Edward L. Kaplan, Paul Meier
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
39,052 Citations1958Edward L. Kaplan, Paul Meier
CA A Cancer Journal for CliniciansCancer statistics, 1999
3,131 Citations1999Sarah Landis, Thomas S. Murray +2 more
The Surveillance Research Program of the American Cancer Society's Department of Epidemiology and Surveillance Research reports its 33rd annual compilation of cancer frequency, incidence, mortality, and survival data for the United States.
PubMedSerum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
555 Citations1993Alan W. Partin, Charles R. Pound +3 more
The long-term value of serum PSA as a measure of progression after anatomic radical prostatectomy is demonstrated and suggests that radiation therapy is not effective in sterilizing occult local residual tumor in many men.
Urologic Clinics of North AmericaSERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY
472 Citations1993Alan W. Partin, Charles R. Pound +3 more
Journal of Clinical OncologyConsensus Statements on Radiation Therapy of Prostate Cancer: Guidelines for Prostate Re-Biopsy After Radiation and for Radiation Therapy With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy
325 Citations1999James D. Cox, M. Gallagher +3 more
The panel judged that prostate re-biopsy is not necessary as standard follow-up care and that the absence of a rising PSA level after radiation therapy is the most rigorous end point of total tumor eradication.
The Journal of UrologyLONG-TERM RESULTS OF RADIATION THERAPY FOR PROSTATE CANCER RECURRENCE FOLLOWING RADICAL PROSTATECTOMY
208 Citations1998Jeffrey A. Cadeddu, A. Partin +2 more
Patients with Gleason score 8 or greater, positive seminal vesicles or lymph nodes, or a PSA recurrence within the first year following surgery rarely benefit from radiation therapy, but as the interval to PSA Recurrence increases, the likelihood of responding to radiation therapy increases substantially.
JNCI Journal of the National Cancer InstituteFollow-up Prostate Cancer Treatments After Radical Prostatectomy: a Population-Based Study
202 Citations1996Grace L. Lu‐Yao, Arnold L. Potosky +4 more
The likelihood of additional cancer therapy after radical prostatectomy is determined using a linked dataset that combined information from the Surveillance, Epidemiology, and End Results Program and Medicare hospital and physician claims.
International Journal of Radiation Oncology*Biology*PhysicsAdjuvant and salvage irradiation following radical prostatectomy for prostate cancer
173 Citations1997Monica Morris, K.C. Dallow +5 more
For patients with stage pT3N0 prostate cancer following radical prostatectomy, the data support the use of either routine postoperative adjuvant irradiation or close PSA follow-up with early salvage treatment.
The Journal of UrologyThe Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen Levels
155 Citations1990Paul H. Lange, Deborah J. Lightner +3 more
It is concluded that radiation therapy after radical prostatectomy can cause elevated prostate specific antigen to decrease to undetectable levels in many patients but the durability and ultimate therapeutic value of this effect are unknown.
The Journal of UrologyADJUVANT RADIATION THERAPY DOES NOT CAUSE URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE RANDOMIZED STUDY
138 Citations1998Paul J. Van Cangh, Françoise Richard +7 more
In this prospective randomized study 60 Gy.
The Journal of UrologyAdjuvant Radiation Therapy in Patients with Detectable Prostate Specific Antigen Following Radical Prostatectomy
136 Citations1991Peter Link, Fuad S. Freiha +1 more
The ability of adjuvant radiation therapy to eliminate serum PSA in patients with a delayed increase in PSA after radical prostatectomy is encouraging, However, longer followup, including the use of nonradiated control subjects, is needed to assess the ability to control local disease and prolong patient survival.
The Journal of UrologyEffect of Radiation Therapy on Detectable Serum Prostate Specific Antigen Levels Following Radical Prostatectomy: Early Versus Delayed Treatment
131 Citations1994John F. McCarthy, William J. Catàlona +1 more
It is concluded that patients with pathological stage C disease who are most likely to benefit from postoperative radiation therapy are those with initially undetectable postoperative PSA levels.
The Journal of UrologyThe Use of Radiotherapy for Patients with Isolated Elevation of Serum Prostate Specific Antigen Following Radical Prostatectomy
129 Citations1996Steven E. Schild, Steven J. Buskirk +5 more
Radiotherapy administered to the prostate bed effectively decreased serum PSA in approximately half of the cases, and this effect appears to be accomplished by eradicating tumor cells in the prostateBed.
International Journal of Radiation Oncology*Biology*PhysicsTolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy
123 Citations1997Michael J. Zeléfsky, Eric Aschkenasy +2 more
After prostatectomy, three-dimensional conformal radiotherapy is associated with minimal treatment-related morbidity and a Cox proportional hazards regression analysis demonstrated that a preradiotherapy PSA value of > 1 ng/ml was the most important covariate predicting for a rising PSA after radiotherapy.
International Journal of Radiation Oncology*Biology*PhysicsThe efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen
111 Citations1995Justin J. Wu, Stephen C. King +3 more
Prostatic-bed RT for an elevated serum PSA after RP is most effective in patients with a pre-RT PSA < or = 2.5 ng/ml, while patients with significantly higher PSA values are unlikely to benefit from RT, possibly due to the presence of occult distant metastases.
UrologyTreatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer
106 Citations1999Frank A. Vicini, Ellen L. Ziaja +5 more
Patients treated with adjuvant RT after prostatectomy for adverse pathologic findings achieved excellent rates of biochemical control that were significantly better than that of similar patients treated therapeutically for persistent or rising PSA or clinical local recurrence.
The Journal of UrologyTHERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL
98 Citations1997Jeffrey D. Forman, Kyle Meetze +5 more
Therapeutic irradiation for patients with elevated PSA postoperatively is highly effective and at a median followup of 36 months 64% of the patients remain disease-free.
International Journal of Radiation Oncology*Biology*PhysicsEffect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer
95 Citations1998Richard K. Valicenti, Leonard G. Gomella +4 more
In patients with pT3N0 prostate cancer after radical prostatectomy, a radiation dose-response function may be present and depends on the preRT PSA value, and patients with high postoperative PSA levels may be less likely to benefit from higher doses of RT, and should be considered a group for which systemic therapy should be tested.
The Journal of UrologyEffect of Adjuvant Radiation Therapy on Prostate Specific Antigen Following Radical Prostatectomy
94 Citations1990M’Liss A. Hudson, William J. Catàlona
Adjuvant radiation therapy decreased serum prostate specific antigen values to the undetectable range in 6 of 21 patients, all of whom have remained free of tumor recurrence with a mean followup of 12.6 months, and further followup will be required to determine what ultimate impact adjuvant radiation Therapy will have on survival free of tumors.
International Journal of Radiation Oncology*Biology*PhysicsMultivariate analysis of factors predicting local relapse after radical prostatectomy—possible indications for postoperative radiotherapy
92 Citations1991Mitchell S. Anscher, Leonard R. Prosnitz
Patients with poorly differentiated tumors, positive surgical margins, or elevated preoperative acid phosphatase are at high risk for local relapse after radical prostatectomy.
UrologyImpact of Postprostatectomy Prostate-Specific Antigen Nadir on Outcomes Following Salvage Radiotherapy
88 Citations1998Madhur Garg, Samuel Tekyi‐Mensah +6 more
Many patients who never achieve an undetectable postprostatectomy PSA level may still be salvaged with therapeutic radiotherapy, and the best predictor of a favorable outcome is a low PSAlevel 2 ng/mL or less at the time of radiation.
International Journal of Radiation Oncology*Biology*PhysicsThe effectiveness of immobilization during prostate irradiation
73 Citations1995Gunilla C. Bentel, Lawrence B. Marks +3 more
This custom-made hemibody foam cradle appears to improve the reproducibility of patient setup during the 7-week course of fractionated external beam irradiation for patients with adenocarcinoma of the prostate.
PubMedSalvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
72 Citations1998T Do, R G Parker +4 more
Salvage radiation therapy is a viable option for post prostatectomy local tumor recurrences and prognosticators for distant metastasis included seminal vesicle invasion and perineural invasion.
UrologySerum prostate-specific antigen after post prostatectomy radiotherapy
67 Citations1992Irving Kaplan, Malcolm A. Bagshaw
External beam radiotherapy was administered to 39 patients after radical prostatectomy for adenocarcinoma, and pathologic analysis of the surgical specimens suggested that positive surgical margins, seminal vesicle or lymph node involvement, or high Gleason pattern scores are associated with measurable PSA after surgery.
International Journal of Radiation Oncology*Biology*PhysicsPreirradiation PSA predicts biochemical disease-free survival in patients treated with postptrostatectomy external beam irradiation
65 Citations1997Christopher H. Crane, Tyvin A. Rich +4 more
Biochemical disease-free survival after postprostatectomy radiation is predicted by the PSA at the time of irradiation, and clinical local control is excellent, but distant failure remains a significant problem in this population.
PubMedTherapeutic radiation in patients with a rising post-prostatectomy PSA level.
54 Citations1998J.D. Forman, J. Cano Velasco
The optimal management of patients with an elevated post-prostatectomy prostate-specific antigen (PSA) level remains to be determined and an appropriate therapeutic option for high-risk patients following prostatectomy would be to wait for an elevated PSA and then proceed with a course of potentially curative radiotherapy.
CancerDelayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy: A long term follow‐up
47 Citations1996Eitan Medini, Iris Medini +2 more
Delayed/salvage radiation therapy appears to be beneficial for patients who had undergone radical prostatectomy only and then developed rising PSA levels during the follow-up period, and a durable decrease in elevated PSA level in 10 patients.
International Journal of Radiation Oncology*Biology*PhysicsPreliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA levels
36 Citations1990Martin Keisch, Carlos A. Perez +3 more
Through preliminary results, these results suggest that post-prostatectomy PSA levels are useful for detecting subclinical local recurrence or persistence in the prostatic bed, as well as monitoring these patients' response to therapy.
CA A Cancer Journal for CliniciansCancer statistics, 1999: challenges in minority populations
29 Citations1999Charles J. McDonald
The incidence rates of breast cancer in young women and lung cancer in men are down, as are those of colon and rectal cancer in both men and women, and US cancer death rates are declining in all major sites.
International Journal of Radiation Oncology*Biology*PhysicsDifferences in gross target volumes on contrast vs. noncontrast CT scans utilized for conformal radiation therapy treatment planning for prostate carcinoma
21 Citations1998Su-Min Zhou, Gunilla C. Bentel +2 more
The addition of i.v. contrast does appear to make a significant difference in how the prostate and seminal vesicles are outlined by an experienced observer, and the increase in area of the target, found when contrast is used, should be taken into consideration when designing the treatment fields for patients with carcinoma of the prostate.
PubMedTreatment options for prostate cancer.
7 Citations1994Patrick M. Lassen, Ian M. Thompson
Analyzing the available literature that reports the results of treatment versus observation for prostate cancer, Fleming et al. found that in most cases, treatment offered less than a 1-year improvement in quality-adjusted life expectancy.
Prostate Cancer and Prostatic DiseasesStandard vs conformal radiation therapy for adenocarcinoma of the prostate: no difference
4 Citations1998J. Bean, GS Montana +5 more
Careful 2D planning for the treatment of localized adenocarcinoma of the prostate is an acceptable means of treatment within the dose range of 64–70 Gy, and this preliminary analysis demonstrated no reduction in complications nor improvement in local or biochemical control, or DFS was seen with the the use of 3D treatment planning.